AUSTRALIAN REGULATORY AFFAIRS · CLINICAL DEVELOPMENT · MARKET ENTRY

Navigate Australian Regulatory Strategy with Confidence

Specialist Australian regulatory strategy, clinical development and market-entry support for pharmaceutical, biotechnology, medical technology and other life-sciences organisations. Tricode can support sponsors before Australia is selected, through feasibility and study start-up, during study conduct, and across TGA registration and lifecycle management.

Discuss Your Australian Strategy

Australian Regulatory Support Across the Product Lifecycle

Tricode Clinical supports defined Australian regulatory workstreams across the study and product lifecycle. Support can begin during early Australian feasibility and continue through regulatory and start-up readiness, ongoing Australian regulatory support during study conduct, changes to sites or providers, TGA registration and lifecycle management.

Australian Regulatory Consultancy

About Tricode Clinical

Tricode Clinical is a specialist Australian regulatory consultancy supporting pharmaceutical, biotechnology and other life-sciences organisations across clinical development, regulatory strategy, Australian clinical trial start-up, including OGTR interactions where relevant, marketing authorisation and approved product lifecycle activities.

Tricode was founded by Peter Lynch, an Australian regulatory affairs leader with more than 25 years of experience across government, pharmaceutical, biotechnology, global CRO and consulting environments.

About Tricode Clinical

Regulatory Support Across the Australian Product Lifecycle

Australian Regulatory Strategy

  • Australian development and market-entry planning
  • TGA pathway and submission strategy
  • Regulatory gap assessment
  • International reliance and work-sharing considerations
  • Regulatory sequencing and program planning
  • Regulatory sequencing informed by broader market-access and commercial planning
Read the Strategic Guide

Clinical Trial Regulatory Support

Specialist support from early Australian feasibility and study-start-up readiness through CTN or CTA, HREC, site and ongoing regulatory activities, working alongside sponsor, CRO and specialist-provider teams.

  • Early Australian feasibility and site landscape
  • CTN or CTA, HREC and start-up readiness
  • Australian trial sponsor requirements and Local Sponsor arrangements
View Clinical Trial Support

TGA Marketing Authorisations

  • Pre-submission strategy
  • Prescription medicine registration support
  • Orphan Drug Designation
  • Priority Review and relevant evaluation pathways
  • TGA liaison and response management
View Marketing Authorisation Support

OGTR and Advanced Therapies

  • OGTR pathway assessment
  • DNIR and DIR applications
  • Institutional Biosafety Committee coordination
  • Gene therapy and GMO clinical trial support
  • Parallel coordination of OGTR and HREC requirements
View OGTR & Advanced Therapies Support

Local Sponsor and Regulatory Agent

Where appropriate, Tricode can accept appointment as the Australian clinical trial sponsor or provide defined Regulatory Agent support while working alongside the sponsor’s existing CRO, sites and specialist providers.

  • Australian trial sponsor role where accepted
  • Defined Regulatory Agent support
  • Clear sponsor, CRO and provider responsibilities
  • Australian regulatory coordination and sponsor oversight
View Local Sponsor Support

Lifecycle Management

  • Variations and notifications
  • Renewals
  • Post-approval regulatory activities
  • Product information support
  • Ongoing Australian regulatory advice
View Lifecycle Management Support

When Clients Engage Tricode Clinical

Clients engage Tricode when they need specialist Australian regulatory judgement, early feasibility and start-up support, ownership of a defined workstream or an appropriate Australian regulatory presence.

Assessing Australia Before Country Selection

For sponsors considering whether Australia is suitable for a study and needing early insight into the site landscape, regulatory requirements, Local Sponsor needs and realistic start-up timing.

Trial Start-Up Readiness

For programs developing regulatory, ethics, site and document readiness while CROs, sites and specialist providers are still being considered.

Local Australian Regulatory Support

For sponsors that need local Australian regulatory support, with Tricode acting as an extension of their team and leading an agreed regulatory or clinical development workstream alongside existing program structures.

Adapting During Study Delivery

For studies requiring ongoing Australian regulatory support when sites, providers, regulatory strategy or the broader operating model change.

Australian regulatory strategyRegulatory judgement, pathway strategy, feasibility and advisory support.

Defined Australian executionOwnership and delivery of agreed regulatory and clinical development workstreams.

Australian regulatory presenceLocal Sponsor or Regulatory Agent responsibilities where appropriate.

Why Tricode Clinical

Specialist Australian Regulatory Expertise

Australian-specific regulatory advice across clinical development, TGA pathways, Local Sponsor requirements and lifecycle activities.

Integrated Australian Development Perspective

Regulatory decisions are considered alongside feasibility, sites, ethics, international sequencing and the wider Australian operating model.

Works With Your Existing CRO and Providers

Tricode can support a defined Australian workstream alongside internal teams, CROs, sites and specialist providers.

Continuity Across the Australian Workstream

Support can continue from early Australian planning through start-up, regulatory change, registration and lifecycle requirements.

Melbourne skyline at night

Why Australia?

Australia can play a valuable role in global development and commercialisation programs, supported by a high-quality clinical research environment and an established regulatory framework.

Clinical Development Environment

Experienced investigators, high-quality research infrastructure and internationally recognised capabilities support early and later-stage clinical development.

Established Regulatory Framework

TGA pathways and established ethics and governance processes provide a defined environment for Australian clinical and regulatory activities.

Strategic Global and Asia-Pacific Role

Australian activities can form part of broader international development, registration and commercialisation planning across global and regional programs.

Upcoming Conferences

BIO-Europe 2026

Autumn meeting · Cologne, Germany ·

Tricode Clinical will be attending BIO-Europe 2026 as part of the Australian delegation.

We will be meeting with international biotechnology and pharmaceutical companies considering Australia for clinical development, early feasibility, regulatory strategy, study start-up and market entry.

Planning an Australian development program? Arrange a meeting with Tricode in Cologne.

Meet Tricode at BIO-Europe 2026

Regulatory Insights and Resources

Cover of Tricode Clinical’s Strategic Guide to Australian Market Entry
STRATEGIC REGULATORY GUIDE

Strategic Guide to Australian Market Entry

Regulatory and market-access insights for organisations evaluating Australian pathways, clinical development opportunities and the interaction between registration, reimbursement and commercial planning.

Download the Report
FEATURED REGULATORY INSIGHT

Australia’s Proposed Gene Technology Reforms: Implications for Cell and Gene Therapy Clinical Trials

A practical update for sponsors on the proposed GMO Permit and non-notifiable pathways, current OGTR requirements and implications for Australian clinical-trial planning.

Read the Insight

Discuss Your Australian Regulatory Strategy

Tell us about your program, regulatory priorities or planned Australian activities. Tricode Clinical will review your enquiry and contact you to arrange an initial discussion.

Please do not include confidential or patient-identifiable information. We can arrange an appropriate confidentiality agreement before discussing sensitive program details.

Your information will be handled in accordance with our Privacy Policy.

Prefer email? You can also contact Tricode Clinical at info@tricodeclinical.com.au.

Defined Scope or Procurement Requirement

Request a Proposal

If your organisation has a defined Australian regulatory, clinical-development or Local Sponsor requirement, you can send a request for proposal or scope of work directly to Tricode Clinical.

Please include the proposed scope, development stage, Australian activities, required services and relevant timing expectations.

Send an RFP to: proposals@tricodeclinical.com

For confidential materials, contact Tricode first so that appropriate confidentiality arrangements can be established.